Reaction
Eosinophilic Pneumonia Chronic reporting signals
As of the last recalculation, Eosinophilic Pneumonia Chronic appears in 297 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 347.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ciclesonide | 55 | 347.1 | 348.5 |
| Mercaptopurine | 27 | 119.9 | 120.1 |
| Fluticasone Furoate | 15 | 91.3 | 91.5 |
| Fluticasone Furoate And Vilanterol Trifenatate | 32 | 69.8 | 69.8 |
| Mepolizumab | 35 | 55.8 | 55.9 |
| Benralizumab | 7 | 25.1 | 25.1 |